Tumor necrosis factor-alpha (TNF) influences a wide variety of cellular functions, including cell growth, cell death and metastases. Although the action of TNF is mediated through its cell surface receptors, the intracellular events that link ligand binding to the cytotoxic action of TNF remain elusive. The overall objective of this grant application is to define the signaling mechanisms that regulate TNF-mediated cell killing. Signaling through TNF receptors (TNFR) is unique. They do not possess any intrinsic kinase activity. It is presumed that upon ligand binding TNFR activate and/or recruit other factors or kinases to convey its signal. The specific focus of this project is to define the functional significance of protein phosphorylation and dephosphorylation in TNF signaling. TNF inhibits the growth of breast cancer cells in vitro but little is known regarding the involvement of TNF in breast cancer pathogenesis. The protein kinase C signal transduction pathway appears to regulate TNF sensitivity in breast cancer cells.
The specific aims of this application are to determine the contribution of PKC isozymes in TNF-mediated cell death, to study the regulation of TNFR function by kinases, to investigate their involvement on the down-stream signaling events of TNF and to determine the basis for TNF resistance in normal and malignant mammary cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071727-01A1
Application #
2397407
Study Section
Special Emphasis Panel (ZRG2-ET-1 (04))
Project Start
1997-09-04
Project End
1998-08-31
Budget Start
1997-09-04
Budget End
1998-08-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Pal, Deepanwita; Outram, Shalini Persaud; Basu, Alakananda (2013) Upregulation of PKC? by PKC? and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival. Biochim Biophys Acta 1830:4040-5
Pal, Deepanwita; Outram, Shalini Persaud; Basu, Alakananda (2012) Novel regulation of protein kinase C-ýý. Biochem Biophys Res Commun 425:836-41
Sridharan, Savitha; Basu, Alakananda (2011) S6 kinase 2 promotes breast cancer cell survival via Akt. Cancer Res 71:2590-9
Shankar, Eswar; Krishnamurthy, Soumya; Paranandi, Rajiv et al. (2010) PKCepsilon induces Bcl-2 by activating CREB. Int J Oncol 36:883-8
Basu, Alakananda; Pal, Deepanwita (2010) Two faces of protein kinase C?: the contrasting roles of PKC? in cell survival and cell death. ScientificWorldJournal 10:2272-84
Basu, Alakananda; Sridharan, Savitha; Persaud, Shalini (2009) Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2. Cell Signal 21:1680-5
Dhar, Rohini; Persaud, Shalini D; Mireles, Joe R et al. (2009) Proteolytic cleavage of p70 ribosomal S6 kinase by caspase-3 during DNA damage-induced apoptosis. Biochemistry 48:1474-80
Basu, Alakananda (2008) Molecular targets of breast cancer: AKTing in concert. Breast Cancer 2:11-16
Basu, Alakananda; Persaud, Shalini D; Sivaprasad, Usha (2008) Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs. Methods Enzymol 446:141-57
Shankar, E; Sivaprasad, U; Basu, A (2008) Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53. Oncogene 27:3957-66

Showing the most recent 10 out of 27 publications